Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 7, pp. 952-965
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 6, 2019
- Revision received October 7, 2019
- Accepted April 2, 2020
- Published first April 7, 2020.
Article Versions
- Previous version (April 7, 2020 - 06:10).
- Previous version (May 22, 2020 - 05:40).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Jiyong Liang1,#,*,
- Lulu Wang2,#,
- Chao Wang1,3,#,
- Jianfeng Shen2,
- Bojin Su1,
- Anantha L. Marisetty4,
- Dexing Fang4,
- Cynthia Kassab4,
- Kang Jin Jeong1,
- Wei Zhao1,
- Yiling Lu1,
- Abhinav K. Jain5,
- Zhicheng Zhou1,
- Han Liang6,
- Shao-Cong Sun7,
- Changming Lu8,
- Zhi-Xiang Xu9,
- Qinghua Yu1,
- Shan Shao1,
- XiaoHua Chen1,
- Meng Gao1,
- Francois X. Claret1,
- Zhiyong Ding1,
- Jian Chen10,
- Pingsheng Chen11,
- Michelle C. Barton5,
- Guang Peng2,
- Gordon B. Mills12,*, and
- Amy B. Heimberger4,*
- 1Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 2Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 3Department of Obstetrics & Gynecology, Obstetrics & Gynecology Hospital of Fu Dan University, Shanghai, China.
- 4Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 5Genes and Development Graduate Program, Department of Epigenetics and Molecular Carcinogenesis, and Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 6Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 7Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 8The Institute of Oral Health, School of Dentistry, University of Alabama at Birmingham, Birmingham, Alabama.
- 9Division of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.
- 10Department of General Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Province, Hangzhou, China.
- 11Department of Pathology, Medical School of Southeast University, Nanjing, Jiangsu, China.
- 12Cell, Developmental & Cancer Biology, Oregon Health and Sciences University, Portland, Oregon.
- ↵*Corresponding Authors:
Amy B. Heimberger, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Boulevard, Unit 442, Houston, TX 77030. Phone: 713-792-2400; Fax: 713-794-4950; E-mail: aheimber{at}mdanderson.org; Jiyong Liang, jyliang{at}mdanderson.org; and Gordon B. Mills, Oregon Health and Sciences University, Portland, OR 97239. E-mail: millsg{at}ohsu.edu
↵#J. Liang, L. Wang, and C. Wang contributed equally to this article.
July 2020
Volume 8, Issue 7
Volume 8, Issue 7
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy
Jump to section
Advertisement